Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Mycoses|June 15, 2011
Anidulafungin: when and how? The clinician's viewJomy George, Annette C Reboli
Current Infectious Disease Reports|June 2, 2014
Nucleoside-sparing antiretroviral regimensPola de la Torre, Jomy George, John D Baxter
AIDS Care|October 26, 2020
Changes in neurocognitive assessment scores after initiating dolutegravir- versus elvitegravir-based antiretroviral therapyJessica L Adams, Yookyung Christy Choi, Michael West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV InfectionRamya Ramaswami, Mark N Polizzotto, Kathryn Lurain, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
AIDS (London, England)|July 18, 2022
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapyKristi Huik, Shawn Hill, Jomy George, et al.
Journal for Immunotherapy of Cancer|February 20, 2021
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphomaKathryn Lurain, Ramya Ramaswami, Ralph Mangusan, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2022
Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy AdultsThomas P Lodise, J Nicholas O'Donnell, Stephen Balevic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2025
International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic PreparednessSafia Kuriakose, Alice Tseng, Sarita Boyd, et al.
Pageof 2